AAAAAA

   
Results: 1-19 |
Results: 19
Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7
Authors: Mercher, T Coniat, MB Khac, FN Ballerini, P Mauchauffe, M Bui, H Pellegrino, B Radford, I Valensi, F Mugneret, F Dastugue, N Bernard, OA Berger, R
Citation: T. Mercher et al., Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7, GENE CHROM, 33(1), 2002, pp. 22-28
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group
Authors: Jourdan, E Reiffers, J Stoppa, AM Sotto, JJ Attal, M Bouabdallaha, R Marit, G Fegueux, N Boulat, O Dastugue, N Boiron, JM Faberes, C Gastaut, JA Maraninchi, D Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia
Authors: Mercher, T Busson-Le Coniat, M Monni, R Mauchauffe, M Khac, FN Gressin, L Mugneret, F Leblanc, T Dastugue, N Berger, R Bernard, OA
Citation: T. Mercher et al., Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia, P NAS US, 98(10), 2001, pp. 5776-5779
Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene
Authors: Greenland, C Dastugue, N Touriol, C Lamant, L Delsol, G Brousset, P
Citation: C. Greenland et al., Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene, J CLIN PATH, 54(2), 2001, pp. 152-154
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report
Authors: Vilmer, E Suciu, S Ferster, A Bertrand, Y Cave, H Thyss, A Benoit, Y Dastugue, N Fournier, M Souillet, G Manel, AM Robert, A Nelken, B Millot, F Lutz, P Rialland, X Mechinaud, F Boutard, P Behar, C Chantraine, JM Plouvier, E Laureys, G Brock, P Uyttebroeck, A Margueritte, G Plantaz, D Norton, L Francotte, N Gyselinck, J Waterkeyn, C Solbu, G Philippe, N Otten, J
Citation: E. Vilmer et al., Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report, LEUKEMIA, 14(12), 2000, pp. 2257-2266
Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia ofinfants/children and a review of 39 cases: report from a t(1;22) study group
Authors: Bernstein, J Dastugue, N Haas, OA Harbott, J Heerema, NA Huret, JL Landman-Parker, J LeBeau, MM Leonard, C Mann, G Pages, MP Perot, C Pirc-Danoewinata, H Roitzheim, B Rubin, CM Slociak, M Viguie, F
Citation: J. Bernstein et al., Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia ofinfants/children and a review of 39 cases: report from a t(1;22) study group, LEUKEMIA, 14(1), 2000, pp. 216-218
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial
Authors: Millot, F Suciu, S Philippe, N Benoit, Y Mazingue, F Uyttebroeck, A Lutz, P Mechinaud, F Robert, A Boutard, P Marguerite, G Ferster, A Plouvier, E Rialland, X Behard, C Plantaz, D Dresse, MF Philippet, P Norton, L Thyss, A Dastugue, N Waterkeyn, C Vilmer, E Otten, J
Citation: F. Millot et al., Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial, J CL ONCOL, 19(7), 2000, pp. 1935-1942
New cytogenetic data on bladder carcinoma cell line (CHA89) revealed by M-FISH analysis
Authors: Perissel, B Giollant, M Dastugue, N Penault-Llorca, F Jaffray, JY Guy, L Boiteux, JP Kemeny, JL Fonck, Y Boucher, D
Citation: B. Perissel et al., New cytogenetic data on bladder carcinoma cell line (CHA89) revealed by M-FISH analysis, CANC GENET, 121(2), 2000, pp. 228-229
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21
Authors: Preudhomme, C Warot-Loze, D Roumier, C Grardel-Duflos, N Garand, R Lai, JL Dastugue, N Macintyre, E Denis, C Bauters, F Kerckaert, JP Cosson, A Fenaux, P
Citation: C. Preudhomme et al., High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21, BLOOD, 96(8), 2000, pp. 2762-2769
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21
Authors: Preudhomme, C Warot-Loze, D Roumier, C Grardel-Duflos, N Garand, R Lai, JL Dastugue, N Macintyre, E Denis, C Bauters, F Kerckaert, JP Cosson, A Fenaux, P
Citation: C. Preudhomme et al., High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21, BLOOD, 96(8), 2000, pp. 2862-2869
Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party
Authors: Grimwade, D Biondi, A Mozziconacci, MJ Hagemeijer, A Berger, R Neat, M Howe, K Dastugue, N Jansen, J Radford-Weiss, I Lo Coco, F Lessard, M Hernandez, JM Delabesse, E Head, D Liso, V Sainty, D Flandrin, G Solomon, E Birg, F Lafage-Pochitaloff, M
Citation: D. Grimwade et al., Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party, BLOOD, 96(4), 2000, pp. 1297-1308
FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)
Authors: Guasch, G Mack, GJ Popovici, C Dastugue, N Birnbaum, D Rattner, JB Pebusque, MJ
Citation: G. Guasch et al., FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33), BLOOD, 95(5), 2000, pp. 1788-1796
De novo and secondary acute myeloid leukemia in patients over the age of 65: a review of fifty-six successive and unselected cases from a general hospital
Authors: Bauduer, F Ducout, L Dastugue, N Capdupuy, C Renoux, M
Citation: F. Bauduer et al., De novo and secondary acute myeloid leukemia in patients over the age of 65: a review of fifty-six successive and unselected cases from a general hospital, LEUK LYMPH, 35(3-4), 1999, pp. 289-296
Diagnosis of acute basophilic leukemia
Authors: Duchayne, E Demur, C Rubie, H Robert, A Dastugue, N
Citation: E. Duchayne et al., Diagnosis of acute basophilic leukemia, LEUK LYMPH, 32(3-4), 1999, pp. 269
Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia
Authors: Raynaud, SD Dastugue, N Zoccola, D Shurtleff, SA Mathew, S Raimondi, SC
Citation: Sd. Raynaud et al., Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia, LEUKEMIA, 13(9), 1999, pp. 1325-1330
Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations
Authors: Busson-Le Coniat, M Salomon-Nguyen, F Dastugue, N Maarek, O Lafage-Pochitaloff, M Mozziconacci, MJ Baranger, L Brizard, F Radford, I Jeanpierre, M Bernard, OA Berger, R
Citation: M. Busson-le Coniat et al., Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations, LEUKEMIA, 13(12), 1999, pp. 1975-1981
Acquisition of a stimulatory activity for V gamma 9/V delta 2 T cells by aBurkitt's lymphoma cell line without loss of HLA class I expression
Authors: L'Faqihi, FE Guiraud, M Dastugue, N Brousset, P Le Bouteiller, P Halary, F Bonneville, M Fournie, JJ Champagne, E
Citation: Fe. L'Faqihi et al., Acquisition of a stimulatory activity for V gamma 9/V delta 2 T cells by aBurkitt's lymphoma cell line without loss of HLA class I expression, HUMAN IMMUN, 60(10), 1999, pp. 928-938
Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases
Authors: Bayle, C Charpentier, A Duchayne, E Manel, AM Pages, MP Robert, A Lamant, L Dastugue, N Bertrand, Y Dijoud, F Emile, JF Machover, D Brugieres, L Delsol, G
Citation: C. Bayle et al., Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases, BR J HAEM, 104(4), 1999, pp. 680-688
A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
Authors: Lamant, L Dastugue, N Pulford, K Delsol, G Mariame, B
Citation: L. Lamant et al., A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation, BLOOD, 93(9), 1999, pp. 3088-3095
Risultati: 1-19 |